SESSION TITLE: Student/Resident Case Report Poster - Diffuse Lung Disease
SESSION TYPE: Student/Resident Case Report Poster
PRESENTED ON: Tuesday, October 25, 2016 at 01:30 PM - 02:30 PM
INTRODUCTION: FOLFOX (5-fluorouracil, leucovorin, and oxaliplatin) is a common chemotherapy regimen for colorectal adenocarcinoma. Preliminary research demonstrated gastrointestinal, neurologic and hematologic side effects1. Subsequent literature revealed that interstitial lung disease (ILD) occurs or is exacerbated by FOLFOX in 0 to 4.2% of cases with oxaliplatin having been established as the causative agent by process of exclusion1,2. We now present a unique case of reversible exacerbation of Idiopathic Pulmonary Fibrosis (IPF) after administration of oxaliplatin.